Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
PsychoGenics logo — Discover Your Next Breakthrough

PsychoGenics

Discover Your Next Breakthrough

Founded 1999 United States Paramus, United States 146 employees Grant Total: $522.00K Biotechnology, Health Care

General Information

Company Name PsychoGenics
Founded Year 1999
Location United States Paramus, United States
Employees 146
Industries Biotechnology, Health Care
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with PsychoGenics. To contact PsychoGenics, visit psychogenics.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About PsychoGenics

PsychoGenics is a preclinical CRO specializing in CNS and orphan disorders, aiming to provide top-tier disease models and comprehensive preclinical capabilities for the discovery of advanced treatments and reduction of attrition rates in clinical development. The company is recognized for its cutting-edge translational research, customized solutions, and the quality of its work. With an extensive portfolio of highly predictive disease models, it has gained unparalleled experience in serving biopharmaceutical companies. Established in 1999 in the United States, PsychoGenics' capabilities include behavioral testing, electrophysiology, translational EEG, quantitative histology, molecular biology, and microdialysis. The company offers a range of validated mouse models supporting research in various areas including Alzheimer’s disease, Huntington’s disease, Parkinson’s disease, autism spectrum disorders, psychosis and schizophrenia, spinal muscular atrophy, muscular dystrophy, and pain models. The latest investment of $522.00K grant was received on the 06 March 2024 from the Reeve Foundation. This investment is set to further support the company's innovative initiatives in the biotechnology and healthcare industries.

Taxonomy: CNS disorders, Orphan disorders, Preclinical CRO, Translational research, Disease models, Behavioral testing, Electrophysiology, Molecular biology, Microdialysis, Quality assurance, Biopharmaceutical, Clinical development, Pharmacology, Neurological disorders, Research and development

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $522.00K 1
Reeve Foundation
06 Mar 2024
Grant Undisclosed 1
National Institute of Mental Health
National Institute of Mental Health
05 Sep 2023

PsychoGenics Alternatives & Competitors

View All Alternatives
PsychoGenics vs
SynapCell
SynapCell France

Evaluate your most effective drug candidates in vivo using objective & translational measurements in...

Series A
41 employees
Biotechnology, Health Care
PsychoGenics vs
NeuCyte
NeuCyte United States

Decoding CNS Drug Discovery with SynFire® iP

Series A
11 employees
Biotechnology, Health Care
PsychoGenics vs
Newron Pharmaceuticals SpA
Newron Pharmaceuticals SpA Italy

The Specialist in CNS Drug Development

Post-IPO Equity
23 employees
Biopharma, Biotechnology
View all alternatives

FAQ About PsychoGenics

Discover Your Next Breakthrough
PsychoGenics was founded in 1999.
PsychoGenics is headquartered in Paramus, United States.
PsychoGenics operates in Biotechnology and Health Care. Its work centres on CNS disorders, Orphan disorders, Preclinical CRO and Translational research.
PsychoGenics has approximately 146 employees.
PsychoGenics has completed 2 funding rounds, raising a total of $522.00K. The latest funding stage is Grant.
Top alternatives and competitors to PsychoGenics include SynapCell, NeuCyte, Newron Pharmaceuticals SpA, Farcast Biosciences, GenFleet Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
PsychoGenics and SynapCell are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for PsychoGenics, https://bouncewatch.com/company/psychogenics, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes